Benir Ruano
Chief Tech/Sci/R&D Officer presso ACADIA PHARMACEUTICALS INC.
Profilo
Benir Ruano is the founder of BDR Life Sciences LLC.
He is currently working as the Senior VP-Technical Development & Operations at ACADIA Pharmaceuticals, Inc. Prior to his current position, he held the role of VP-Global Manufacturing & Technical Operations at Xeris Pharmaceuticals, Inc. and VP-Manufacturing Operations & Supply Chain at Tarsus Pharmaceuticals, Inc. Mr. Ruano has an MBA from National University and an undergraduate degree from the University of California San Diego.
Posizioni attive di Benir Ruano
Società | Posizione | Inizio |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Precedenti posizioni note di Benir Ruano
Società | Posizione | Fine |
---|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
BDR Life Sciences LLC | Founder | - |
TARSUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Benir Ruano
National University | Masters Business Admin |
University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
TARSUS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
BDR Life Sciences LLC |
- Borsa valori
- Insiders
- Benir Ruano